Cargando…
Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases
In this mini-review, we highlight selected research by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence “Precision Medicine in Chronic Inflammation” focusing on clinical sequencing and the clinical utility of polygenic risk scores as well as its implication on precision medicine in th...
Autores principales: | Hübenthal, Matthias, Löscher, Britt-Sabina, Erdmann, Jeanette, Franke, Andre, Gola, Damian, König, Inke R., Emmert, Hila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901950/ https://www.ncbi.nlm.nih.gov/pubmed/33633722 http://dx.doi.org/10.3389/fimmu.2020.577677 |
Ejemplares similares
-
Clinical utility of polygenic scores for cardiometabolic disease in Arabs
por: Shim, Injeong, et al.
Publicado: (2023) -
Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology
por: Qassim, Ayub, et al.
Publicado: (2021) -
The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
por: Sud, Amit, et al.
Publicado: (2021) -
Clinical utility of polygenic risk scores: a critical 2023 appraisal
por: Koch, Sebastian, et al.
Publicado: (2023) -
Validity and Prognostic Value of a Polygenic Risk Score for Parkinson’s Disease
por: Koch, Sebastian, et al.
Publicado: (2021)